NM_012120.3:c.-267G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_012120.3(CD2AP):​c.-267G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 561,740 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00082 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 10 hom. )

Consequence

CD2AP
NM_012120.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.471

Publications

0 publications found
Variant links:
Genes affected
CD2AP (HGNC:14258): (CD2 associated protein) This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. [provided by RefSeq, Jul 2008]
CD2AP-DT (HGNC:55263): (CD2AP divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-47477978-G-A is Benign according to our data. Variant chr6-47477978-G-A is described in ClinVar as Benign. ClinVar VariationId is 357155.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000815 (124/152074) while in subpopulation SAS AF = 0.00974 (47/4824). AF 95% confidence interval is 0.00753. There are 0 homozygotes in GnomAd4. There are 68 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012120.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD2AP
NM_012120.3
MANE Select
c.-267G>A
5_prime_UTR
Exon 1 of 18NP_036252.1Q9Y5K6
CD2AP-DT
NR_187257.1
n.95C>T
non_coding_transcript_exon
Exon 1 of 1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD2AP
ENST00000359314.5
TSL:1 MANE Select
c.-267G>A
5_prime_UTR
Exon 1 of 18ENSP00000352264.5Q9Y5K6
CD2AP
ENST00000931707.1
c.-267G>A
5_prime_UTR
Exon 1 of 18ENSP00000601766.1
CD2AP
ENST00000931708.1
c.-267G>A
5_prime_UTR
Exon 1 of 18ENSP00000601767.1

Frequencies

GnomAD3 genomes
AF:
0.000823
AC:
125
AN:
151958
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00994
Gnomad FIN
AF:
0.0000948
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000692
Gnomad OTH
AF:
0.00240
GnomAD4 exome
AF:
0.00170
AC:
698
AN:
409666
Hom.:
10
Cov.:
3
AF XY:
0.00239
AC XY:
517
AN XY:
216032
show subpopulations
African (AFR)
AF:
0.000219
AC:
2
AN:
9130
American (AMR)
AF:
0.000488
AC:
8
AN:
16410
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12312
East Asian (EAS)
AF:
0.0000372
AC:
1
AN:
26858
South Asian (SAS)
AF:
0.0113
AC:
486
AN:
43114
European-Finnish (FIN)
AF:
0.000110
AC:
3
AN:
27358
Middle Eastern (MID)
AF:
0.00386
AC:
7
AN:
1814
European-Non Finnish (NFE)
AF:
0.000679
AC:
169
AN:
248778
Other (OTH)
AF:
0.000921
AC:
22
AN:
23892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000815
AC:
124
AN:
152074
Hom.:
0
Cov.:
32
AF XY:
0.000914
AC XY:
68
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41534
American (AMR)
AF:
0.000850
AC:
13
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5150
South Asian (SAS)
AF:
0.00974
AC:
47
AN:
4824
European-Finnish (FIN)
AF:
0.0000948
AC:
1
AN:
10550
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000692
AC:
47
AN:
67940
Other (OTH)
AF:
0.00237
AC:
5
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000318
Hom.:
0
Bravo
AF:
0.000635
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Focal segmental glomerulosclerosis 3, susceptibility to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
14
DANN
Benign
0.97
PhyloP100
0.47
PromoterAI
-0.0047
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs532229799; hg19: chr6-47445714; API